about
The optimum timing to wean invasive ventilation for patients with AECOPD or COPD with pulmonary infectionResolvin D1 attenuates polyinosinic-polycytidylic acid-induced inflammatory signaling in human airway epithelial cells via TAK1Differential inflammatory response to inhaled lipopolysaccharide targeted either to the airways or the alveoli in manPathophysiology of viral-induced exacerbations of COPDCadmium attenuates the macrophage response to LPS through inhibition of the NF-κB pathwayMortality rates for chronic lower respiratory diseases in Italy from 1979 to 2010: an age-period-cohort analysisComputerised Analysis of Telemonitored Respiratory Sounds for Predicting Acute Exacerbations of COPD.Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study.Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial.Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.Features of self-management interventions for people with COPD associated with improved health-related quality of life and reduced emergency department visits: a systematic review and meta-analysis.The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, CanadaHuman rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary diseaseExacerbations in patients with chronic obstructive pulmonary disease receiving physical therapy: a cohort-nested randomised controlled trial.Relationship between the GOLD combined COPD assessment staging system and bacterial isolationAlterations in the expression of the NF-κB family member RelB as a novel marker of cardiovascular outcomes during acute exacerbations of chronic obstructive pulmonary disease.Markers of exacerbation severity in chronic obstructive pulmonary diseaseThe role of interleukin-1 and interleukin-18 in pro-inflammatory and anti-viral responses to rhinovirus in primary bronchial epithelial cells.Three-month treatment response and exacerbation in chronic obstructive pulmonary disease.Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE studyCritical role of CFTR-dependent lipid rafts in cigarette smoke-induced lung epithelial injury.Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema.Utility of the CAT in the therapy assessment of COPD exacerbations in China.Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization?Value of arterial blood gas analysis in patients with acute dyspnea: an observational study.A pilot study of the impact of high-frequency chest wall oscillation in chronic obstructive pulmonary disease patients with mucus hypersecretion.Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease.Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study.Hochu-ekki-to inhibits rhinovirus infection in human tracheal epithelial cells.Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD.Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjectsAirway mucus: From production to secretion.Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease.COPD exacerbations . 2: aetiologyEffective mucus clearance is essential for respiratory health.History of pneumonia is a strong risk factor for chronic obstructive pulmonary disease (COPD) exacerbation in South Korea: the Epidemiologic review and Prospective Observation of COPD and Health in Korea (EPOCH) study.The role of bronchodilator treatment in the prevention of exacerbations of COPD.Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD.COPD exacerbations by disease severity in England
P2860
Q26752876-C6147814-3C2A-4497-BBC1-31B694B716E0Q28249812-5CB4A3EA-97A1-44E5-A807-B4EC723E9B1CQ28383064-AB247757-F3B6-4926-82E9-DB4CA8FA80CDQ28389402-5F255047-755C-431F-BA65-8128963BBD76Q28396001-3486568E-FC72-4F89-8B74-07C7BF064AEEQ28596682-FB010D99-B047-4BD3-80EF-0325E3378264Q30398378-FCA0F7F6-858E-4771-B2B3-054E0C067E1CQ33398817-06CF67BE-C055-40F4-B3F2-95F89EABD3C1Q33721432-29798087-030F-4434-B952-8F972DBED3D5Q33772323-38AC176C-54CA-45A3-81E2-A9F233696E89Q33806782-A706C3BE-C2F3-4E9E-9821-CD8B1222F71FQ33868106-BB678E87-53E7-4D24-8A36-A798D01210BFQ33898138-51180EF7-CA5B-4B97-91C8-344D5B938A47Q33938723-66B6C389-AC20-4BFF-BD74-7B1856F3B6A6Q34293156-914B50B7-8F49-44AA-ADD3-3E9C9A758FC2Q34542055-CCA8B3B4-901D-4928-A8AE-40CAE7DED0EEQ34691221-58795379-9F1B-47AD-8E0E-1E682BC89EEFQ34749235-65AA4E18-1D2E-4740-84CC-D1E1C4050D23Q34779478-EBA3ACA9-A32A-46C8-B042-DE6897BD6BDDQ34944637-A9E518B5-F11D-44AF-87E1-F1E8B4023B58Q35057070-F9E3866F-7EA2-4A58-B389-1E232AF508B2Q35059259-B90C5F59-1FCD-48C4-944F-1B06823AD9B6Q35117371-B9BF9B57-D83E-4032-AC5D-07D7B05AB44DQ35240244-4752CD41-1F46-48E1-B777-50728B7976D2Q35558333-4E95F788-D07B-4804-9516-0B11A9F92B9AQ35671708-3133C013-4822-4FF6-84D6-FAD2397A5ED4Q35825949-C0F3EB5B-F6D1-4BB8-9321-71AF0EAEA45EQ35862715-E1F7A0BC-E6AB-4464-9745-1CF505BE31A4Q36052536-C99FBD5E-7D0C-46CB-9F6E-EB008AF68318Q36087058-BFAD597C-3384-4FB6-BC74-69DA368921E6Q36146801-CA957E78-F5C3-4E17-987B-4DF322A5E6C0Q36183894-498E7E0F-E29C-43A3-ABE5-AEA965813865Q36369409-54A5CF24-C7DE-43CB-969C-69E3116D2779Q36388372-52096435-EB3F-4350-87A6-CAE9A97AD551Q36414253-061D971F-5115-46A6-A001-F4C78D53D38BQ36417678-1735F610-094E-434D-A31B-69F436A33142Q36437545-D505DD34-5900-461D-99A7-7DA009556746Q36438669-DFE58981-39CA-456C-B569-1B5D12FEBAADQ36444197-6E4F0FC9-D368-433D-A566-22313713FE93Q36776335-1153652F-A419-4624-A84A-EE2B966FC9A2
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Exacerbations of chronic obstructive pulmonary disease.
@ast
Exacerbations of chronic obstructive pulmonary disease.
@en
type
label
Exacerbations of chronic obstructive pulmonary disease.
@ast
Exacerbations of chronic obstructive pulmonary disease.
@en
prefLabel
Exacerbations of chronic obstructive pulmonary disease.
@ast
Exacerbations of chronic obstructive pulmonary disease.
@en
P1433
P1476
Exacerbations of chronic obstructive pulmonary disease
@en
P2093
Gavin C Donaldson
Jadwiga A Wedzicha
P304
1204-13; discussion 1213-5
P577
2003-12-01T00:00:00Z